http://www.zibb.com/all/theme/cq/Antigenics+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Mon, 23 Nov 2009 07:07:51 GMTMon, 23 Nov 2009 07:07:51 GMT608831http://www.zibb.com/all/theme/cq/Antigenics+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5686676/Analyst+Choice+Updated+Analysis+on+DENTSPLY+International+Inc+PAETEC+Holding+Corp+Antigenics+Inc+Cubist+Pharmaceuticals+Inc+Alkermes+Inc+and+Biogen+Idec+IncAll ten sectors ended in the red today led by technology, financial and energy sectors. Consumer staples and healthcare sectors registered the least losses. This drove us to do research on the following 6 stocks DENTSPLY International Inc. (NASDAQ: XRAY), PAETEC Holding Corp. (NASDAQ: PAET),http://www.zibb.com/article/5686676/Analyst+Choice+Updated+Analysis+on+DENTSPLY+International+Inc+PAETEC+Holding+Corp+Antigenics+Inc+Cubist+Pharmaceuticals+Inc+Alkermes+Inc+and+Biogen+Idec+IncAntigenics IncorporatedMon, 23 Nov 2009 07:07:51 GMThttp://abcnews.go.com/Business/wireStory?id=9137103Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate.http://abcnews.go.com/Business/wireStory?id=9137103Antigenics IncorporatedFri, 20 Nov 2009 15:52:47 GMThttp://www.biospace.com/news_story.aspx?StoryID=163547&full=1A negative vote of the CHMP indicating this opinion was verbally conveyed to Antigenics and announced in a press release issued on October 21, 2009.http://www.biospace.com/news_story.aspx?StoryID=163547&full=1Antigenics IncorporatedFri, 20 Nov 2009 12:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10001Antigenics, Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline’s (GSK) Phase III malaria vaccine clinical trial, containing Antigenics’ QS-21 Stimulon® adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10001Antigenics IncorporatedWed, 04 Nov 2009 01:00:00 GMThttp://seekingalpha.com/article/169934-antigenics-q3-2009-earnings-call-transcript?source=feedAntigenics (AGEN)Q3 2009 Earnings CallOctober 29, 2009 11:00 AM ETCompletehttp://seekingalpha.com/article/169934-antigenics-q3-2009-earnings-call-transcript?source=feedAntigenics IncorporatedThu, 29 Oct 2009 20:01:11 GMThttp://www.xconomy.com/boston/2009/10/28/european-regulators-question-antigenics-and-biogen-idec-drugs-bioassets-bags-30m-in-option-deal-more-boston-area-life-sciences-news/Europe’s drug regulators were not kind to a couple of Massachusetts biotech firms this week, but other New England life sciences companies had happier news tohttp://www.xconomy.com/boston/2009/10/28/european-regulators-question-antigenics-and-biogen-idec-drugs-bioassets-bags-30m-in-option-deal-more-boston-area-life-sciences-news/Antigenics IncorporatedWed, 28 Oct 2009 04:14:23 GMThttp://www.marketwatch.com/story/genzyme-slides-on-outlook-antigenics-tanks-2009-10-21?siteid=yhoofDrug stocks trend lower as shares of Genzyme Corp. retreat after the company issues a lower 2009 forecast.http://www.marketwatch.com/story/genzyme-slides-on-outlook-antigenics-tanks-2009-10-21?siteid=yhoofAntigenics IncorporatedWed, 21 Oct 2009 18:18:00 GMThttp://www.thestreet.com/_yahoo/story/10596882/1/antigenics-vaccine-booster-baked-into-valuation-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAInvestor presentation shows why this company's shares are over-priced. Check out TheStreet for the latest stock market news and financial investment headlines.http://www.thestreet.com/_yahoo/story/10596882/1/antigenics-vaccine-booster-baked-into-valuation-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAAntigenics IncorporatedThu, 10 Sep 2009 15:35:41 GMThttp://www.pharmaceutical-business-review.com/news/advaxis_seals_collaboration_agreement_with_city_of_hope_090819For the development of a vaccine to treat certain forms of leukemia and lymphomahttp://www.pharmaceutical-business-review.com/news/advaxis_seals_collaboration_agreement_with_city_of_hope_090819Antigenics IncorporatedWed, 19 Aug 2009 00:00:00 GMThttp://www.bizjournals.com/boston/stories/2009/08/10/daily42.html?ana=from_rssDrug developer Antigenics Inc. is enrolling patients in a Phase 2 clinical trial for a potential vaccination to treat a specific form of brain and spinal cancer.http://www.bizjournals.com/boston/stories/2009/08/10/daily42.html?ana=from_rssAntigenics IncorporatedThu, 13 Aug 2009 15:16:25 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3124013&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3124013&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2131021703%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3124013&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3124013&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2131021703%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAntigenics IncorporatedTue, 11 Aug 2009 00:53:58 GMThttp://finance.yahoo.com/news/Antigenics-to-Raise-10-bw-3502495610.html?x=0&.v=1LEXINGTON, Mass.--(BUSINESS WIRE)--Antigenics Inc. (NASDAQ: AGEN - News) today announced that it has entered into definitive agreements to sellhttp://finance.yahoo.com/news/Antigenics-to-Raise-10-bw-3502495610.html?x=0&.v=1Antigenics IncorporatedTue, 04 Aug 2009 13:30:00 GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/06/15/financial/f111307D14.DTL&feed=rss.businessBiotechnology company Antigenics Inc. on Monday named former Sanofi-Aventis executive Timothy Rothwell to its board of directors. Rothwell, 58, was president, chairman and CEO of Sanofi-Aventis U.S. for two years and announced his retirement in February. He...http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/06/15/financial/f111307D14.DTL&feed=rss.businessAntigenics IncorporatedMon, 15 Jun 2009 18:13:36 GMThttp://www.newsvine.com/_news/2009/06/15/2932763-antigenics-names-former-sanofi-us-ceo-to-boardBiotechnology company Antigenics Inc. on Monday named former Sanofi-Aventis executive Timothy Rothwell to its board of directors.http://www.newsvine.com/_news/2009/06/15/2932763-antigenics-names-former-sanofi-us-ceo-to-boardAntigenics IncorporatedMon, 15 Jun 2009 18:13:07 GMThttp://www.fool.com/investing/high-growth/2009/06/11/10-stocks-to-shake-the-market.aspxSome stocks are one-hit wonders, making a big splash when they first appear, only to quickly fizzle into obscurity or oblivion. But for other stocks, that initial big move is only a preview for even bigger and better gains to come.http://www.fool.com/investing/high-growth/2009/06/11/10-stocks-to-shake-the-market.aspxAntigenics IncorporatedThu, 11 Jun 2009 20:07:11 GMThttp://www.gurufocus.com/news.php?id=21190GuruFocus tracks the stock buys, sells and commentaries of stock investment gurus such as Warren Buffett, George Soros, the best investors.http://www.gurufocus.com/news.php?id=21190Antigenics IncorporatedMon, 21 Jan 2008 17:48:33 GMThttp://www.ft.com/cms/s/e5db2b9a-ba4e-11dc-abcb-0000779fd2ac,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fe5db2b9a-ba4e-11dc-abcb-0000779fd2ac.html%3Fnclick_check%3D1&_i_referer=&nclick_check=1Trials showed its vaccine against all ‘A’ strains of the virus was well tolerated, the biotechnology group said on Thursday, although immunity increased when used with an immunological agent made by Antigenics.http://www.ft.com/cms/s/e5db2b9a-ba4e-11dc-abcb-0000779fd2ac,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2Fe5db2b9a-ba4e-11dc-abcb-0000779fd2ac.html%3Fnclick_check%3D1&_i_referer=&nclick_check=1Antigenics IncorporatedFri, 04 Jan 2008 02:25:00 GMThttp://www.icis.com/Articles/2004/06/04/587032/cancer-vaccines-advance-to-commercialization-but-challenges-lie-ahead-in-the-road-to.htmlDespite significant commercial potential, cancer vaccines remain an elusive opportunity.http://www.icis.com/Articles/2004/06/04/587032/cancer-vaccines-advance-to-commercialization-but-challenges-lie-ahead-in-the-road-to.htmlAntigenics IncorporatedFri, 04 Jun 2004 19:35:55 GMThttp://topics.nytimes.com/top/news/business/companies/antigenics-inc/index.htmlGet Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics New York Times Business World U.S. N.Y. / Region Business Technology Science Health Sports Opinion Arts Style Travel Jobs Real Estate Autos Search Business Financial Tools Select a Financial Toolhttp://topics.nytimes.com/top/news/business/companies/antigenics-inc/index.htmlAntigenics Incorporatedhttp://pharmabioingredients.com/news/2006/07/10/antigenics_expands_collaboration_with_gskUnder the expanded agreement, GlaxoSmithKline Biologicals will purchase part of its supply requirements for the adjuvant QS-21 from Antigenics through 2014. Antigenics company will transfer manufacturing technologies to GlaxoSmithKline.http://pharmabioingredients.com/news/2006/07/10/antigenics_expands_collaboration_with_gskAntigenics Incorporatedhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2006-10-11/1011200633359VW.html"Hy's research has formed the basis for the development of several novel immunotherapeutic agents for a variety of different cancers," said Garo H. Armen, PhD,...http://www.newsrx.com/newsletters/Vaccine-Weekly/2006-10-11/1011200633359VW.htmlAntigenics Incorporatedhttp://www.zibb.com/article/5683949/European+CHMP+Formally+Adopts+Negative+Opinion+on+Oncophage+RAntigenics Inc. (NASDAQ: AGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as ahttp://www.zibb.com/article/5683949/European+CHMP+Formally+Adopts+Negative+Opinion+on+Oncophage+RAntigenics IncorporatedFri, 20 Nov 2009 08:25:00 GMThttp://www.zibb.com/article/5629999/Antigenics+Inc+AGEN+Corporate+Event+Announcement+NoticeAntigenics, Inc. (AGEN) Expected next earnings release: Announcement date: 10/29/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Verified Expected next investor conference call information: Conference Call Date: 10/29/2009 Conference Call Time (ET): 11:00 AM Conference Call URL:http://www.zibb.com/article/5629999/Antigenics+Inc+AGEN+Corporate+Event+Announcement+NoticeAntigenics IncorporatedThu, 29 Oct 2009 20:40:27 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9158Antigenics (NASDAQ: AGEN)today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9158Antigenics IncorporatedMon, 26 Oct 2009 01:00:00 GMThttp://seekingalpha.com/article/168157-tough-decisions-for-antigenics?source=feedEP Vantage submits:News that the European advisory committee will adopt a negative opinion next month on Antigenics (AGEN) kidney cancerhttp://seekingalpha.com/article/168157-tough-decisions-for-antigenics?source=feedAntigenics IncorporatedThu, 22 Oct 2009 15:32:01 GMT